3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
10
Lung Neoplasms
9
Colorectal Neoplasms
7
Breast Neoplasms
7
Prostatic Neoplasms
6
Rectal Neoplasms
3
Polycystic Ovary Syndrome
3
Neoplasm Metastasis
3
Colonic Neoplasms
3
Stomach Neoplasms
2
Smoking Cessation
2
Neoplastic Cells, Circulating
2
Motor Activity
2
Lymphoma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia
2
Endometrial Neoplasms
2
Disease
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Venous Thromboembolism
1
Vaginal Neoplasms
1
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer
1
Testicular Germ Cell Tumor
1
Stroke
1
Solitary Pulmonary Nodule
1
Skin Neoplasms
1
Sezary Syndrome
1
Interventions
Radiosurgery
5
Androgen Antagonists
4
enzalutamide
2
Prednisone
2
Docetaxel
2
talazoparib
1
sipuleucel-T
1
rucaparib
1
olaparib
1
gallium 68 PSMA-11
1
darolutamide
1
cabazitaxel
1
apalutamide
1
XRP6258
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Positron Emission Tomography Computed Tomography
1
Pluvicto
1
Lutetium-177
1
Lutetium
1
Lenograstim
1
Hematologic Tests
1
Granulocyte Colony-Stimulating Factor
1
Gonadotropin-Releasing Hormone
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Prostate Cancer Metastatic
×
Hematologic Tests
×
Clear all
NCT03223727
2023-04-18
ROTOR
The Netherlands Cancer Institute
Completed
100 enrolled